Chromadex Dividend 2024

Chromadex Dividend

0 USD

Chromadex Dividend yield

Ticker

CDXC

ISIN

US1710774076

WKN

A2AG5N

How much dividend does Chromadex 2024 pay?

According to the latest status from May 2024, Chromadex paid a total of 0 USD per share in dividends within the last 12 months. With the current Chromadex price of 3.12 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Chromadex Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Chromadex Dividend Safe?

Chromadex has been increasing the dividend for 0 years.

Over the past 10 years, Chromadex has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Chromadex's Dividend Distributions

Chromadex’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Chromadex's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Chromadex's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Chromadex’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Chromadex Aktienanalyse

What does Chromadex do?

The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Chromadex stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about Chromadex Stock

How much dividend does Chromadex pay?

Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.

What is the dividend yield of Chromadex?

The current dividend yield of Chromadex is .

When does Chromadex pay dividends?

Chromadex pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chromadex?

Chromadex paid dividends every year for the past 0 years.

What is the dividend of Chromadex?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chromadex located?

Chromadex is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chromadex from 5/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/25/2024.

When did Chromadex pay the last dividend?

The last dividend was paid out on 5/25/2024.

What was the dividend of Chromadex in the year 2023?

In the year 2023, Chromadex distributed 0 USD as dividends.

In which currency does Chromadex pay out the dividend?

The dividends of Chromadex are distributed in USD.

Andere Kennzahlen von Chromadex

Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.